- Home
- SUGP vs AEON Comparison
SUGP vs AEON Comparison
Compare SUGP & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUGP
- AEON
- Stock Information
- Founded
- SUGP 1998
- AEON N/A
- Country
- SUGP Hong Kong
- AEON United States
- Employees
- SUGP N/A
- AEON N/A
- Industry
- SUGP
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- SUGP
- AEON Health Care
- Exchange
- SUGP NYSE
- AEON Nasdaq
- Market Cap
- SUGP 20.3M
- AEON 21.6M
- IPO Year
- SUGP 2024
- AEON N/A
- Fundamental
- Price
- SUGP $1.17
- AEON $0.15
- Analyst Decision
- SUGP
- AEON Strong Buy
- Analyst Count
- SUGP 0
- AEON 1
- Target Price
- SUGP N/A
- AEON $5.00
- AVG Volume (30 Days)
- SUGP 510.4K
- AEON 45.9M
- Earning Date
- SUGP 01-28-2025
- AEON 11-13-2024
- Dividend Yield
- SUGP N/A
- AEON N/A
- EPS Growth
- SUGP N/A
- AEON N/A
- EPS
- SUGP 0.10
- AEON 0.34
- Revenue
- SUGP $20,252,232.00
- AEON N/A
- Revenue This Year
- SUGP N/A
- AEON N/A
- Revenue Next Year
- SUGP N/A
- AEON N/A
- P/E Ratio
- SUGP $11.40
- AEON $0.45
- Revenue Growth
- SUGP N/A
- AEON N/A
- 52 Week Low
- SUGP $0.76
- AEON $0.10
- 52 Week High
- SUGP $5.86
- AEON $17.17
- Technical
- Relative Strength Index (RSI)
- SUGP 46.38
- AEON 27.61
- Support Level
- SUGP $1.09
- AEON $0.10
- Resistance Level
- SUGP $1.26
- AEON $0.22
- Average True Range (ATR)
- SUGP 0.14
- AEON 0.05
- MACD
- SUGP 0.01
- AEON -0.02
- Stochastic Oscillator
- SUGP 34.15
- AEON 10.04
About SUGP SU GROUP HLDGS LTD
SU Group Holdings Ltd and its subsidiaries is an integrated security-related services company. The company has two reportable segments: security-related engineering services, and security guarding and screening services and related vocational training services. The company generates the majority of its revenue from the security-related engineering services segment.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.